Key statistics
As of last trade Foghorn Therapeutics Inc. (FHTX:NMQ) traded at 7.99, -22.05% below its 52-week high of 10.25, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.83 |
---|---|
High | 8.10 |
Low | 7.55 |
Bid | 7.94 |
Offer | 8.03 |
Previous close | 7.72 |
Average volume | 131.78k |
---|---|
Shares outstanding | 55.59m |
Free float | 45.04m |
P/E (TTM) | -- |
Market cap | 429.18m USD |
EPS (TTM) | -1.91 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:10 GMT.
More ▼
- Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
- Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update
- Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors
- Foghorn Therapeutics to Participate in the BMO Oncology Summit
- Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer
- Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September
- Foghorn Therapeutics Provides Second Quarter 2024 Financial and Corporate Update
- Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
- Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
More ▼